Aesthetic Medicine Market, By Product Outlook (Energy-Based Devices, Implants, Anti-Wrinkle Products), By Application Outlook (Surgical, Non-surgical) By End Users (Medical Spas & Beauty Centers, Hospitals & Clinics, Home Use), By Region - Global Analysis Forecast Till 2030

The aesthetic medicine market is expected to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030, with a value of USD 100.1 billion in 2021.

Aesthetic medicines, also called cosmetic treatments, are non-surgical procedures used to reduce the signs of aging, rejuvenate, and refresh the skin. Medical aesthetics encompasses a wide range of solutions and medicines that address specific customer demands and aesthetic needs for fine lines and wrinkle reduction, fat reduction, stretch mark solutions, scar treatment, skin oxygenation, body contours and firming botulinum toxin enhancements, and skin repair.

Acceptance for aesthetic medicinal procedures has grown exponentially in recent years, owing to the rapid outreach of Healthcare Providers (HCPs), patients, and other stakeholders via social media and other digital platforms. This has improved communication between HCPs and patients who are hesitant to undergo such procedures. This is expected to increase the adoption of aesthetic medical devices and products in the coming years. Aesthetic medicinal formulation manufacturers meet customer demands by researching consumer needs by region.

Individuals in China, for example, require facial alterations through medical procedures. Another factor expected to drive aesthetic medicine market revenue growth during the forecast period is an increase in service outlets providing aesthetic medicinal solutions. Aesthetic service centers and clinics have raised over USD 3 billion, and the value is expected to rise in the coming years.

Market Dynamics

Drivers:

The preference for minimally invasive or non-invasive aesthetic procedures over traditional surgical procedures has grown significantly over the last decade. Today's cosmetic surgeons have many tools and techniques, making minimally invasive procedures like eye lifts and facelift more accessible. Furthermore, compared to traditional surgical procedures, minimally invasive/nonsurgical alternatives provide less pain, less scarring, and faster recovery. These procedures are also less expensive than conventional surgical procedures.

Restraints:

Medical aesthetic procedures have a variety of side effects. Patients undergoing aesthetic treatments may experience several risks and complications following or during the procedure. It also depends on the patient’s ability to heal. Infection, excessive bleeding, and anesthesia issues are some of the complications of reconstructive cosmetic surgery. When procedures are performed in by untrained individuals, the risk of complications increases. The majority of these complications are frequently unreported.

Key players:

• Allergan,

• Galderma Laboratories

• Merz Pharmaceuticals

• Alma Lasers

• Johnson & Johnson,

• Galderma

• Lumenis

• Cynosure

• Cutera

• Solta Medical

Market Segmentation:

Aesthetic Medicine Market, By Product Outlook

• Energy-Based Devices

• Implants

• Anti-Wrinkle Products

Aesthetic Medicine Market, By Application Outlook

• Surgical

• Non-surgical

Aesthetic Medicine Market, By End Users

• Medical Spas & Beauty Centers

• Hospitals & Clinics

• Home Use

Aesthetic Medicine Market, By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

Regional Analysis:

During the forecast period, the Asia-Pacific market is expected to grow faster in revenue. Demand from countries such as China, India, and South Korea is helping to drive aesthetic medicine market revenue growth. The rise of medical tourism, particularly in Asian countries, is expected to drive aesthetic medicine market revenue growth in the region. GOURI, the world's first completely injectable liquid polycaprolactone, developed by DEXLEVO, an Asia-based aesthetic and medical device company, has been named the best injectable in the 20th Aesthetic & Anti-aging Medicine World Congress (AMWC), which will be held between March 31 and April 2, 2022. This will likely increase the use of liquid PCL injectables in aesthetic medical centers in the coming years.

The European aesthetic medicine market is expected to grow at a steady CAGR over the forecast period. This is due to a growing emphasis on physical appearance, the availability of technologically advanced products, and the development of cosmetic surgery hubs in this region's countries. Institutions such as the European College of Aesthetic Medicine & Surgery (ECAMS) and the European Society for Cosmetic and Aesthetic Dermatology (ESCAD), which offer a variety of courses on aesthetic medicine and surgical procedures, are expected to raise awareness and adoption of aesthetics in the region, driving revenue growth in the European Aesthetic Medicine market.

Scope of the Report:

User

Tab Content